Robert L Ohsfeldt

Summary

Affiliation: Texas A and M Health Science Center
Country: USA

Publications

  1. ncbi Use of a health information exchange system in the emergency care of children
    Joshua R Vest
    Health Policy and Management, Jiann Ping Hsu College of Public Health, Georgia Southern University, 501 Forest Drive, Statesboro, GA 30460, USA
    BMC Med Inform Decis Mak 11:78. 2011
  2. ncbi A longitudinal study of chiropractic use among older adults in the United States
    Paula Weigel
    Department of Health Management and Policy, College of Public Health, The University of Iowa, Iowa City, Iowa, USA
    Chiropr Osteopat 18:34. 2010
  3. ncbi Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
    Eric S Meadows
    Eli Lilly and Company, Indianapolis, IN, USA
    BMC Womens Health 7:6. 2007
  4. ncbi Defining emergency department episodes by severity and intensity: A 15-year study of Medicare beneficiaries
    Brian Kaskie
    Department of Health Management and Policy, College of Public Health, The University of Iowa, Iowa City, Iowa, USA
    BMC Health Serv Res 10:173. 2010
  5. ncbi Older adults who persistently present to the emergency department with severe, non-severe, and indeterminate episode patterns
    Brian Kaskie
    Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa, USA
    BMC Geriatr 11:65. 2011
  6. ncbi Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Robert L Ohsfeldt
    Texas A and M Health Science Center, Department of Health Policy and Management, College Station, TX 77840, USA
    Am J Manag Care 12:S412-23. 2006
  7. ncbi Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX 77843 1266, USA
    Value Health 11:1061-9. 2008
  8. ncbi Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    J Med Econ 15:125-33. 2012
  9. ncbi Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    J Med Econ 13:428-37. 2010
  10. ncbi An attempt to forecast hospital market share using admission data
    Bita A Kash
    Department of Health Policy and Management, School of Rural Public Health, Texas A and M University Health Science Center, College Station, USA
    J Healthc Manag 54:44-55; discussion 55-6. 2009

Collaborators

Detail Information

Publications19

  1. ncbi Use of a health information exchange system in the emergency care of children
    Joshua R Vest
    Health Policy and Management, Jiann Ping Hsu College of Public Health, Georgia Southern University, 501 Forest Drive, Statesboro, GA 30460, USA
    BMC Med Inform Decis Mak 11:78. 2011
    ..While information exchange capability is a required feature of the certified electronic health record, we known little regarding how this technology is used in general and for pediatric patients specifically...
  2. ncbi A longitudinal study of chiropractic use among older adults in the United States
    Paula Weigel
    Department of Health Management and Policy, College of Public Health, The University of Iowa, Iowa City, Iowa, USA
    Chiropr Osteopat 18:34. 2010
    ..abstract:..
  3. ncbi Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia
    Eric S Meadows
    Eli Lilly and Company, Indianapolis, IN, USA
    BMC Womens Health 7:6. 2007
    ..The objective of the present study was to evaluate the cost-effectiveness of raloxifene, alendronate and conservative care in this population...
  4. ncbi Defining emergency department episodes by severity and intensity: A 15-year study of Medicare beneficiaries
    Brian Kaskie
    Department of Health Management and Policy, College of Public Health, The University of Iowa, Iowa City, Iowa, USA
    BMC Health Serv Res 10:173. 2010
    ....
  5. ncbi Older adults who persistently present to the emergency department with severe, non-severe, and indeterminate episode patterns
    Brian Kaskie
    Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa, USA
    BMC Geriatr 11:65. 2011
    ..In this research, we classified older adults into population groups that persistently present with severe, non-severe, or indeterminate patterns of ED episodes. We then contrasted the three groups using a comprehensive set of covariates...
  6. ncbi Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
    Robert L Ohsfeldt
    Texas A and M Health Science Center, Department of Health Policy and Management, College Station, TX 77840, USA
    Am J Manag Care 12:S412-23. 2006
    ..The objective of the present study was to estimate the clinical effectiveness and cost-effectiveness of rosuvastatin compared with atorvastatin or simvastatin among high-risk patients as treated in routine clinical practice...
  7. ncbi Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX 77843 1266, USA
    Value Health 11:1061-9. 2008
    ..To compare the effectiveness and cost-effectiveness among generic and branded statins in routine clinical practice...
  8. ncbi Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    J Med Econ 15:125-33. 2012
    ..This study estimated the long-term health outcomes, healthcare costs, and cost-effectiveness of rosuvastatin 20 mg therapy in primary prevention of major cardiovascular disease (CVD) in a Swedish population...
  9. ncbi Cost effectiveness of rosuvastatin in patients at risk of cardiovascular disease based on findings from the JUPITER trial
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    J Med Econ 13:428-37. 2010
    ..This study assessed the long-term cost effectiveness of rosuvastatin therapy compared with placebo in reducing the incidence of major cardiovascular (CVD) events and mortality...
  10. ncbi An attempt to forecast hospital market share using admission data
    Bita A Kash
    Department of Health Policy and Management, School of Rural Public Health, Texas A and M University Health Science Center, College Station, USA
    J Healthc Manag 54:44-55; discussion 55-6. 2009
    ..The value of this type of research for management is explored here as well...
  11. ncbi Medical and cost burden of atherosclerosis among patients treated in routine clinical practice
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    J Med Econ 13:500-7. 2010
    ..This investigation estimated medical costs attributable to treatment of patients diagnosed with atherosclerosis in routine US clinical practice...
  12. ncbi Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring
    Robert L Ohsfeldt
    Texas A and M Health Science Center, College Station, TX, USA
    Curr Med Res Opin 25:1403-11. 2009
    ..This study assessed lipid-monitoring and statin therapy patterns in routine clinical practice for Medicare-eligible patients diagnosed with atherosclerosis...
  13. ncbi Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting
    Kathleen M Fox
    Am J Manag Care 13:S270-5. 2007
    ..The study compared low-density lipoprotein cholesterol (LDL-C) reduction obtained after switching patients on a statin therapy to rosuvastatin or simvastatin in real-world clinical practice...
  14. ncbi Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective
    Kathleen M Fox
    University of Maryland School of Medicine, Department of Epidemiology and Preventive Medicine, Baltimore, MD, USA
    Curr Med Res Opin 23:2125-33. 2007
    ..To compare effectiveness of rosuvastatin (RSV) with other statins on lowering low-density lipoprotein cholesterol (LDL-C) and LDL-C goal attainment among patients with type 1 or type 2 diabetes mellitus...
  15. ncbi Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database
    Kathleen M Fox
    Department of Epidemiology and Preventive Medicine, School of Medicine, University of Maryland, Baltimore, MD, USA
    Clin Ther 29:2385-94. 2007
    ..Lipid management in clinical practice has been suboptimal with a significant proportion of patients not achieving recommended cholesterol levels. A reason for low goal attainment may be the limited use of upward dose titration...
  16. ncbi Cost effectiveness of a point-of-care test for adenoviral conjunctivitis
    Belinda L Udeh
    Health Economics Consulting Group, LLC, Morristown, New Jersey, USA
    Am J Med Sci 336:254-64. 2008
    ..Clinical differentiation between adenoviral and bacterial conjunctivitis is difficult, often resulting in misdiagnosis and the provision of inappropriate treatment...
  17. ncbi Health professionals' assessment of health-related quality of life values for oral clefting by age using a visual analogue scale method
    George L Wehby
    College of Public Health, Department of Health Management and Policy, University of Iowa, Iowa City, Iowa 52242-1181, USA
    Cleft Palate Craniofac J 43:383-91. 2006
    ..The clustered pattern of HRQL values suggests either a consensus among evaluators of a limited burden of oral clefting or an overall lack of understanding of the evaluation task...
  18. ncbi Cost-effectiveness of tamsulosin, doxazosin, and terazosin in the treatment of benign prostatic hyperplasia
    Robert L Ohsfeldt
    Department of Health Management and Policy, College of Public Health, University of Iowa, Iowa City, Iowa 52242, USA
    J Manag Care Pharm 10:412-22. 2004
    ..To evaluate the cost-effectiveness of tamsulosin, doxazosin, or terazosin as initial treatments for moderate benign prostatic hyperplasia (BPH) over a 3-year time horizon from a health-system-payer perspective...
  19. ncbi Modeling the annual costs of postmenopausal prevention therapy: raloxifene, alendronate, or estrogen-progestin therapy
    C Daniel Mullins
    University of Maryland School of Pharmacy, 515 W Lombard St, Room 262, Baltimore, MD 21201 1563, USA
    J Manag Care Pharm 9:150-8. 2003
    ..To estimate the annual cost and outcome impacts attributable to raloxifene, alendronate, and estrogen-progestin therapy as prevention therapies among postmenopausal women over the first 7 years of hormone replacement therapy (HRT)...